Investors


Financial and regulatory information

2026 Financial calendar


2025 Year-end resultsApril 2026
2026 Half-year resultsOctober 2026

NCX 470 (bimatoprost grenod) – Mont Blanc Data and Value Proposition

NCX 470 (bimatoprost grenod) – Denali Phase 3 Study Topline Results

Regulatory information

This section contains information provided for under article 221-1 of the Règlement général de l’AMF.


Voting rights

This section contains information provided for under article 221-1 of the AMF General Regulation
Older documents